PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19.
Palma G, Pasqua T, Silvestri G, Rocca C, Gualtieri P, Barbieri A, De Bartolo A, De Lorenzo A, Angelone T, Avolio E, Botti G.
Palma G, et al. Among authors: pasqua t.
Front Immunol. 2020 Aug 21;11:2094. doi: 10.3389/fimmu.2020.02094. eCollection 2020.
Front Immunol. 2020.
PMID: 32973818
Free PMC article.
Review.